Northern Trust
PLSE icon

Northern Trust’s Pulse Biosciences PLSE Stock Holding History

Northern Trust’s Portfolio PLSE Stock Details PLSE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.04M Buy
187,272
+3,021
+2% +$55.8K ﹤0.01% 2572
2025
Q4 		$2.53M Sell
184,251
-8,360
-4% -$130K ﹤0.01% 2863
2025
Q3 		$3.41M Sell
192,611
-4,817
-2% -$76.2K ﹤0.01% 2720
2025
Q2 		$2.98M Sell
197,428
-7,077
-3% -$117K ﹤0.01% 2773
2025
Q1 		$3.29M Sell
204,505
-5,953
-3% -$111K ﹤0.01% 2642
2024
Q4 		$3.66M Buy
210,458
+262
+0.1% +$4.62K ﹤0.01% 2695
2024
Q3 		$3.69M Buy
210,196
+29,031
+16% +$495K ﹤0.01% 2649
2024
Q2 		$2.03M Sell
181,165
-5,979
-3% -$56.3K ﹤0.01% 2888
2024
Q1 		$1.63M Buy
187,144
+3,479
+2% +$32K ﹤0.01% 3067
2023
Q4 		$2.25M Buy
183,665
+4,877
+3% +$33.8K ﹤0.01% 2933
2023
Q3 		$721K Buy
178,788
+1,522
+0.9% +$9.46K ﹤0.01% 3398
2023
Q2 		$1.27M Buy
177,266
+102,617
+137% +$656K ﹤0.01% 3261
2023
Q1 		$251K Buy
74,649
+869
+1% +$2.62K ﹤0.01% 3751
2022
Q4 		$204K Sell
73,780
-390
-0.5% -$876 ﹤0.01% 3864
2022
Q3 		$171K Buy
74,170
+2,117
+3% +$3.44K ﹤0.01% 3933
2022
Q2 		$110K Sell
72,053
-97,783
-58% -$246K ﹤0.01% 4137
2022
Q1 		$825K Sell
169,836
-6,744
-4% -$55.2K ﹤0.01% 3520
2021
Q4 		$2.62M Sell
176,580
-2,105
-1% -$41.9K ﹤0.01% 3092
2021
Q3 		$3.86M Sell
178,685
-10,545
-6% -$227K ﹤0.01% 2900
2021
Q2 		$3.1M Sell
189,230
-7,644
-4% -$145K ﹤0.01% 3130
2021
Q1 		$4.66M Sell
196,874
-41,883
-18% -$1.25M ﹤0.01% 2791
2020
Q4 		$5.7M Sell
238,757
-13,542
-5% -$215K ﹤0.01% 2606
2020
Q3 		$2.97M Sell
252,299
-6,321
-2% -$68K ﹤0.01% 2849
2020
Q2 		$2.71M Buy
258,620
+104,216
+67% +$938K ﹤0.01% 2867
2020
Q1 		$1.1M Buy
154,404
+7,125
+5% +$73.9K ﹤0.01% 3168
2019
Q4 		$1.98M Buy
147,279
+6,191
+4% +$88.2K ﹤0.01% 3139
2019
Q3 		$2.18M Buy
141,088
+16,812
+14% +$218K ﹤0.01% 3053
2019
Q2 		$1.64M Buy
124,276
+2,454
+2% +$33.5K ﹤0.01% 3168
2019
Q1 		$2.14M Buy
121,822
+791
+0.7% +$12.4K ﹤0.01% 3044
2018
Q4 		$1.39M Buy
121,031
+11,212
+10% +$136K ﹤0.01% 3240
2018
Q3 		$1.56M Buy
109,819
+2,493
+2% +$35.4K ﹤0.01% 3334
2018
Q2 		$1.63M Buy
107,326
+14,231
+15% +$241K ﹤0.01% 3304
2018
Q1 		$1.26M Sell
93,095
-3,361
-3% -$63.8K ﹤0.01% 3303
2017
Q4 		$2.28M Sell
96,456
-1,333
-1% -$31.5K ﹤0.01% 3071
2017
Q3 		$1.82M Buy
97,789
+235
+0.2% +$5.34K ﹤0.01% 3236
2017
Q2 		$3.37M Buy
97,554
+87,385
+859% +$2.4M ﹤0.01% 2858
2017
Q1 		$208K Buy
+10,169
New +$138K ﹤0.01% 3784

Other funds holding PLSE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PCM
Portolan Capital Management Boston, Massachusetts $1.88B AUM 115.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
GAM
Griffin Asset Management New York $949M AUM 24.98% 1-Year Est. Return
LP
LMR Partners London, United Kingdom $45.4B AUM 60.68% 1-Year Est. Return

Northern Trust's PLSE Position: Q1 2026 in Review

Northern Trust increased its Pulse Biosciences (PLSE) stake by 1.6% in Q1 2026, buying an estimated $55.8K and bringing the position to 187,272 shares worth $4.04M. The position accounts for ﹤0.01% of the portfolio, ranked #2572.

Northern Trust first reported a position in PLSE in Q1 2017 and has held it in 37 quarters since. The position peaked at $5.7M in Q4 2020. 96 funds tracked by Wall St. Rank hold PLSE as of Q1 2026.

  • Northern Trust held 187,272 shares of Pulse Biosciences worth $4.04M as of Q1 2026.
  • Northern Trust bought 3,021 Pulse Biosciences shares in Q1 2026, an estimated $55.8K.
  • Pulse Biosciences made up ﹤0.01% of Northern Trust's portfolio in Q1 2026, its #2572 holding.
  • Northern Trust first reported a position in Pulse Biosciences in Q1 2017 and has held it in 37 quarters since.
  • Northern Trust's Pulse Biosciences position peaked at $5.7M in Q4 2020.
  • 96 funds tracked by Wall St. Rank held Pulse Biosciences as of Q1 2026.

Based on Northern Trust's 13F filing for Q1 2026, filed 14 May 2026.